Canadian health officials recently shared their “cautious optimism” regarding the decrease in opioid toxicity deaths, with two of the three provinces responsible for most fatalities showing a similar downward trend. However, the situation in Alberta stands out.
Last year, there were 5,630 reported opioid overdose deaths across Canada, marking a 23% reduction from the previous year. While Ontario, British Columbia, and Alberta collectively contribute to nearly 80% of these deaths, Alberta experienced a mere 4% decline, contrasting with the larger drops in Ontario (38%) and B.C. (22%).
Alberta witnessed a significant increase of approximately 65% in EMS responses to suspected opioid-related overdoses last year, while Ontario and B.C. reported fewer responses. Health Canada spokesperson Mark Johnson attributed Alberta’s unique situation to shifts in its illegal drug supply, notably detecting higher levels of fentanyl, fentanyl analogues, benzodiazepines, and tranquilizers like medetomidine.
According to Johnson, regional disparities in drug markets and illegal drug supplies are influenced by factors such as trafficking routes, organized crime presence, local demand, and service accessibility.
Alberta ranked third among all provinces and territories in terms of opioid-related deaths per 100,000 individuals last year. Although federal data indicated an increase in hospitalizations for opioid-related poisonings in Alberta, the provincial website suggests a slight decrease.
Notably, the Alberta government did not provide a response when approached for comments on these statistics. DJ Larkin, the executive director of the Canadian Drug Policy Coalition, highlighted the impact of variable drug supplies on national outcomes, suggesting that delayed government actions might also contribute to the statistics.
Larkin emphasized that the decline in deaths in provinces like B.C. and Ontario could be attributed to previous fatalities rather than effective interventions. Alberta experienced a sharper decline in deaths in 2024 following a record high in opioid overdoses.
As EMS responses to opioid-related incidents rose, Elaine Hyshka, an associate professor at the University of Alberta’s School of Public Health, pointed out an increased contamination of illegal drugs with sedatives. She raised concerns about the lack of outreach teams and day shelter spaces leading to delayed overdose responses.
The disparities between Edmonton and Calgary in overdose death totals last year were notable, with Calgary aligning with the national trend of declining deaths while Edmonton reported a rise. Hyshka attributed these differences to varying drug supplies and highlighted the impact of crackdowns on public drug use in Edmonton.
Despite the reported declines in opioid-related deaths across provinces and U.S. states with different policy responses, Hyshka suggested that the progress is not solely linked to specific policies. She expressed concerns about the potential spikes in mortality rates following the announced closure of supervised consumption sites in Calgary and Lethbridge, advocating for a comprehensive range of addiction services.
In conclusion, the complex interplay of factors like drug supplies, government actions, and service accessibility underscores the multifaceted nature of addressing the opioid crisis in Canada.
